"We are on the verge of a revolution in medicine: understanding, treating, and ultimately preventing the causes of degenerative aging. But medical revolutions only happen if we all stand up in support of funding and research. We did it for cancer. We're doing it for Alzheimer's. We can do it for aging - and create an era of longer, healthier lives!"

Email Contact
reason -at- fightaging -dot- org

  
Search

The Causes of Aging
Accumulating AGEs
Buildup of Amyloid Between Cells
The Failing Immune System
Declining Lysosomal Function
Mitochondrial DNA Damage
Senescent Cells
Other Causes of Aging

Required Reading
Calorie Restriction
The Community, Visualized
Cryonics
Engineered Negligible Senescence
Envisaging a World Without the FDA
Healthy Life Extension Explained
Introductory Articles
Longevity Meme Newsletter
The Odds of Human Longevity Mutations
The Need For Activism and Advocacy
Stem Cells, Regenerative Medicine
Twelve Ways to Extend Mouse Life Span
The Vital Debate in Aging Research
What is Anti-Aging?

Initiatives
Biogerontology Research Foundation
Campaign Against Aging
Campaign for Aging Research
LifeStar Institute
Immortality Institute
Maximum Life Foundation
Methuselah Foundation
Mprize for Longevity Research
Science Against Aging (Translate)
SENS Foundation

Benefiting From Medical Research
How to Read Scientific Research
Researching Therapies and Clinical Trials

Objections Answered
Boredom
Inequality and Economics
Overpopulation
Stagnation
Being Older for Longer?
What About Retirement?

Recent Entries

  • Looking Ahead to Mitochondrial DNA Replacement Therapies
  • Spermidine and Another Vote For Autophagy
  • Raising the Dead
  • Why Live Another 20 Years?
  • An Intriguing View of Alzheimer's Disease
  • Another Run at Making Old Stem Cells Act As Though Young
  • A Little More Heat Shock Protein Manipulation Work
  • The Layperson's View of Aging and Longevity Science
  • A Small Selection of Calorie Restriction Mimetic Drug Research
  • Reports From a Youthful Cryonics Meeting
  • Thoughts on Scientific Consensus
  • Rapamycin Longevity May Stack With Calorie Restriction Longevity
  • An Update From Sierra Sciences: Cure Aging or Die Trying
  • Statins as a Model for the Spread of Early Longevity Drugs
  • The Campaign Against Aging
  • Alternative Lengthening of Telomeres: ALT 101
  • The Prospect of Cancer Does Not Worry Me
  • A Project For 2010: 10,000 People, $1 Million For Longevity Science
  • A Message on Aging From the Science for Life Extension Foundation
  • A Defense of Programmed Aging

    Blogs of Interest
    Accelerating Future
    Ageing Research
    Alcor News
    Al Fin Longevity
    April's CR Diary
    Andart
    Biosingularity
    CRON Diary
    Cryonics Society
    Depressed Metabolism
    Distributed Republic
    Ethical Technology Blog
    Existence is Wonderful
    Foresight Institute
    Future Current
    FuturePundit
    grailsearch.org
    green light go
    HumanPlus
    In Search of Enlightenment
    Longevity Science
    Marginal Revolution
    Maximum Life Foundation Blog
    Metamagician and the Hellfire Club
    Metamodern
    Methuselah Foundation Blog
    Mises Economics Blog
    Ouroboros
    Overcoming Bias
    Pimm - Partial immortalization
    Responsible Nanotechnology
    ScienceBlogs
    Sentient Developments
    Singularity Hub
    Singularity Institute Blog
    Sonia Arrison
    The Speculist

    Archives (Monthly)

    February 2010
    January 2010
    December 2009
    November 2009
    October 2009
    September 2009
    August 2009
    July 2009
    June 2009
    May 2009
    April 2009
    March 2009
    February 2009
    January 2009
    December 2008
    November 2008
    October 2008
    September 2008
    August 2008
    July 2008
    June 2008
    May 2008
    April 2008
    March 2008
    February 2008
    January 2008
    December 2007
    November 2007
    October 2007
    September 2007
    August 2007
    July 2007
    June 2007
    May 2007
    April 2007
    March 2007
    February 2007
    January 2007
    December 2006
    November 2006
    October 2006
    September 2006
    August 2006
    July 2006
    June 2006
    May 2006
    April 2006
    March 2006
    February 2006
    January 2006
    December 2005
    November 2005
    October 2005
    September 2005
    August 2005
    July 2005
    June 2005
    May 2005
    April 2005
    March 2005
    February 2005
    January 2005
    December 2004
    November 2004
    October 2004
    September 2004
    August 2004
    July 2004
    June 2004
    May 2004
    April 2004
    March 2004
    February 2004
    January 2004

    Creative Commons

    Creative Commons License

    Fight Aging! is published under the Creative Commons Attribution 3.0 license. In short, this means that you are encouraged to republish and rewrite Fight Aging! content in any way you see fit, the only requirements being that you (a) link to the original, (b) attribute the author, and (c) attribute Fight Aging!.

  • Friday, September 4, 2009

    SENS4 Conference Coverage From Ouroboros

    Ouroboros contributer Kristen Fortney is covering the 4th Strategies for Engineered Negligible Senescence conference, presently underway in Cambridge. A wide range of researchers are gathered for one of the few scientifically respectable conferences to focus on the elimination of aging and repair of age-related damage in the old - though a lot of the work presented yesterday only pertains to slowing the progress of aging.

    Some selected excerpts from the first two days of the conference are linked below, and you might want to wander over to the SENS Foundation website and look at the conference presentation abstracts or the program to see what's coming up next.

    SENS4, Session 1: Combating oxidation

    Cathy Clarke tested an original and interesting approach to avoiding free radical damage to poly-unsaturated fatty acids, or PUFAs: isotope reinforcement. ... The basic idea here, explained in an earlier paper, is very simple: heavier isotopes make stronger bonds, so isotope-reinforced PUFAs will be more resistant to free radical attack. Will these results transfer to higher organisms? Is there any chance that the deuterium could get incorporated into other molecules, stabilizing proteins that we want to degrade? The authors plan to follow up this study in worms and mice.

    SENS4, Session 3: Optimising metabolism against aging

    Stephen Spindler described his (ongoing) project to screen a large number of potential lifespan-affecting compounds in mice - so far, several candidates look promising. Interestingly, he also argued that the majority of previous studies measuring the effects of various compounds on rodent life expectancy suffer from serious flaws. In particular, he argued that many of them were confounded by a possible calorie restriction effect: mice are picky eaters, and if you change their diet by adding some compound to it, they will often eat less of it.

    SENS4, Session 4: Adult regenerative capacity

    Brandon Reines presented a counterintuitive result on regeneration: sometimes old animals have a higher regenerative capacity than young animals. In particular, if you punch a hole in the ear of a young mouse, then it won’t heal; but in a middle-aged mouse it will heal completely. He argued that this happens because mouse ear connective tissues never fully differentiate, and suggested that other neural-crest-derived connective tissues might show similar properties.

    SENS4, Session 5: Eliminating recalcitrant intracellular molecules: the lysosome

    John Schloendorn discussed ongoing work at the SENS Foundation Research Center to develop new enzymes that can degrade harmful intracellular junk that accumulates with age. So far, they have discovered enzymes that can degrade A2E and 7-ketocholesterol, which are implicated in macular degeneration and osteoporosis, respectively. Their next step will be to construct a drug delivery system to get these enzymes to lysozomes ... On the lighter side, Schloendorn also described some of the Center’s methods for building functional lab equipment on the cheap, all good examples for aspiring DIY biologists.

    SENS4, Session 6: Eliminating recalcitrant intracellular molecules: other

    Claude Wischik spoke about preventing aggregation of tau protein, which is implicated in Alzheimer’s disease. Clinical trials of their aggregation-inhibiting drug Rember are promising: it seems to slow the down the rate of cognitive decline in patients with mild to moderate Alzheimer’s disease.

    SENS4, Sessions 9 and 10: Rejuvenating extracellular material

    Kendall Houk gave a very interesting talk on computationally designing enzymes from scratch. They plan to apply their recently published protocol to develop enzymes that can reverse the formation of Advanced Glycation End-products (AGEs) - sugar-modified proteins that accumulate with age and are implicated in several age-related diseases.

    Posted by Reason

     
    Share |

    Posted by: Danila Medvedev at September 7, 2009 12:26 AM

    Interesting how badly organised science is. You write "The authors plan to follow up this study in worms and mice." In any other environment such as the military, business or even government, such lack of planning and forethought would be very unlikely if not impossible. It would never occur to any competent manager to allow Clarke's experiments without some form of longer term planning, contingency plans, decision making trees, etc.

    It could similar to this: "Our overall goal in this project is this and we choose to test this approach. If you achieve these specific results, we will allocate this funding to several next steps, which we outline in advance."

    Only in science can projects be funded on no basis of rational analysis whatsoever, in a totally random fashion and without any forethough (or afterthough or any thought for that matter). It's amazing that we see any progress in science under such conditions.

    [Posted by: Danila Medvedev at September 7, 2009 12:26 AM]

    Posted by: Michael G.R. at September 8, 2009 3:08 PM

    While planning is important, too much of it can also be a problem.

    That's part of the reason why high risk, high potential return projects don't get funded enough. Because they are too uncertain, and it's hard to write the grant proposal when you don't know what's going to happen.

    "If we knew what we were doing, it wouldn't be called research, would it?" -- Albert Einstein.

    [Posted by: Michael G.R. at September 8, 2009 3:08 PM]

    Post a comment; thoughtful, considered opinions are valued. Please note that comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.










    Remember personal info?